Department of Medicinal Chemistry, University of Minnesota, 8-101 Weaver Densford Hall, 308 Harvard Street SE, Minneapolis, MN 55455, USA.
Lillehei Heart Institute, University of Minnesota, 4-165 CCRB, 2231 6th Street SE, Minneapolis, MN 55455, USA.
Free Radic Biol Med. 2018 May 20;120:89-101. doi: 10.1016/j.freeradbiomed.2018.03.010. Epub 2018 Mar 11.
Myocardial infarction (MI) is a life-threatening condition that can occur when blood flow to the heart is interrupted due to a blockage in one or more of the coronary vessels. Current treatments of MI rapidly restore blood flow to the affected myocardium using thrombolytic agents or angioplasty. Adverse effects including inflammation, tissue necrosis, and ventricular dysfunction are, however, not uncommon following reperfusion therapy. These conditions are thought to be caused by a sudden influx of reactive oxygen species (ROS) to the affected myocardium. We employed the model of left anterior descending artery ligation/reperfusion surgery in a rat model to show that ischemia/reperfusion injury is associated with the formation of toxic DNA-protein cross-links (DPCs) in cardiomyocytes. Mass spectrometry based experiments have revealed that these conjugates were formed by a free radical mechanism and involved thymidine residues of DNA and tyrosine side chains of proteins (dT-Tyr). Quantitative proteomics experiments have identified nearly 90 proteins participating in hydroxyl radical-induced DPC formation, including ROS scavengers, contractile proteins, and regulators of apoptosis. Global proteome changes were less pronounced and included increased expression of mitochondrial proteins required for aerobic respiration and biomarkers of sarcomere breakdown following ischemia/reperfusion injury. Overall, our results are consistent with a model where sudden return of oxygen to ischemic tissues induces oxidative stress, inflammation, and the formation of DNA-protein cross-links that may contribute to reperfusion injury by desregulating gene expression and inducing cardiomyocyte death.
心肌梗死(MI)是一种危及生命的疾病,当心脏的血流由于一条或多条冠状动脉阻塞而中断时就会发生。目前的 MI 治疗方法是通过使用溶栓剂或血管成形术迅速恢复受影响心肌的血流。然而,再灌注治疗后,炎症、组织坏死和心室功能障碍等不良反应并不少见。这些情况被认为是由于受影响的心肌中活性氧(ROS)的突然涌入引起的。我们在大鼠模型中采用左前降支结扎/再灌注手术模型,表明缺血/再灌注损伤与心肌细胞中有毒 DNA-蛋白质交联(DPC)的形成有关。基于质谱的实验表明,这些共轭物是通过自由基机制形成的,涉及 DNA 的胸腺嘧啶残基和蛋白质的酪氨酸侧链(dT-Tyr)。定量蛋白质组学实验鉴定了近 90 种参与羟基自由基诱导的 DPC 形成的蛋白质,包括 ROS 清除剂、收缩蛋白和细胞凋亡的调节剂。整体蛋白质组变化不明显,包括有氧呼吸所需的线粒体蛋白质表达增加,以及缺血/再灌注损伤后肌节分解的生物标志物。总的来说,我们的结果与一种模型一致,即在缺氧组织中氧气突然返回会引起氧化应激、炎症和 DNA-蛋白质交联的形成,这可能通过调节基因表达和诱导心肌细胞死亡来导致再灌注损伤。